An increased concentration of rifampicin bonded to gelatin-sealed dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge

Vascular

Volumn 6, Issue 3, 1998, Pages 268-273

  Vicaretti, M ^a   Hawthorne, W J ^a   ao, P Y ^a   Fletcher, J P ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

epidermidis; gelatin sealed Dacron; graft infection; rifampicin; Staphylococcus aureus

Indexed keywords

RIFAMPICIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DACRON IMPLANT; GRAFT INFECTION; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DRUG DELIVERY SYSTEMS; GELATIN; METHICILLIN RESISTANCE; POLYETHYLENE TEREPHTHALATES; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; SHEEP; STAPHYLOCOCCAL INFECTIONS;

EID: 0032102750     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099800600309     Document Type: Article

References (36)

1. Iiekweg W. G. Jr., Greenfield L. J., Vascular prosthetic infections: Collected experience and results of treatment. Surgery, 1977, 81, 335–342.
2. Bunt T. J., Synthetic vascular graft infections. I. Graft infections. Surgery, 1983, 93, 733–746.
3. Fletcher J. P., Dryden M., Sorrell T. C., Infection of vascular prosthesis. Australian and New Zealand Journal of Surgery, 1991, 61, 432–435.
4. Goldstone J., Moore W. S., Infection in vascular prosthesis: Clinical manifestations and surgical management. American Journal of Surgery, 1974, 128, 225–233.
5. Bandyk D. F., Berni G. A., Thiele B. L., Towne J. B., Aortofemoral graft infection due to Staphylococcus epidermidis. Archives of Surgery, 1984, 119, 102–108.
6. Bandyk D. F., Bergamini T. M., Kinney E. V., et al, In situ replacement of vascular prosthesis infected by bacterial biofilms. Journal of Vascular Surgery, 1991, 13, 575–583.
7. Moore W. S., Cole C. W., Infection in prosthetic vascular grafts. In Vascular Surgery: A Comprehensive Review, ed. Moore W. S. W. B. Saunders, Philadelphia, 1991, pp. 598–609.
8. Lorentzen J. E., Neilson O. M., Arendrup H., et al, Vascular graft infection: An analysis of sixty-two infections in 2411 consecutively implanted synthetic vascular grafts. Surgery, 1985, 98, 81–86.
9. Calligaro K. D., Veith F. J., Schwarzt M. L., et al, Are Gram-negative bacteria a contraindication to selective graft preservation of infected arterial grafts? Journal of Vascular Surgery, 1992, 16, 337–346.
10. Macbeth G. A., Rubin J. R., McIntyre K. E. Jr., et al, The relevance of arterial wall microbiology to the treatment of prosthetic graft infections: Graft infection vs arterial infection. Journal of Vascular Surgery, 1984, 1, 750–756.
11. Sardelic F., Ao P. Y., Taylor D. A., Fletcher J. P., Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin soaked gelatin sealed Dacron. Cardiovascular Surgery, 1996, 4, 389–392.
12. Sardelic F., Ao P. Y., Fletcher J. P., Efficacy of rifampicin impregnated graft in reducing methicillin resistant Staphylococcus aureus vascular graft infection in a sheep model. Surgery Research Communications, 1994, 15, 205–210.
13. Koneman E. W., Allen S. D., Dowell V. R. Jr., Sommers H. M., Color Atlas and Textbook of Diagnostic Microbiology, 2nd edn. Philadelphia: J. B. Lippincott Company, 1983.
14. Bunt T. J., Sources of Staphylococcus epidermidis at the inguinal incision during peripheral revascularisation. American Surgery, 1986, 52, 472–473.
15. Levy M. F., Schmitt D. D., Edmiston C. E., et al, Sequential analysis of staphylococcal colonization of body surface cultures on patients undergoing vascular surgery. Journal of Clinical Microbiology, 1990, 28, 664–669.
16. Harvey R. A., Greco R. S., The noncovalent bonding of antibiotics to a plytetrafluroethylene benzalkonium graft. Annals of Surgery, 1981, 194, 642–647.
17. Shue W. B., Worosilo S. C., Donetz A. P., et al, Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft. Journal of Vascular Surgery, 1988, 8, 600–605.
18. Chervu A., Moore W. S., Chvapil M., Henderson T., Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. Journal of Vascular Surgery, 1991, 13, 897–901.
19. Nielsen O. M., Noer H. H., Jorgensen L. G., Lorentzen J. E., Gentamicin beads in the treatment of localized vascular graft infection—long-term results in 17 cases. European Journal of Vascular Surgery, 1991, 5, 283–285.
20. Shah P. M., Modak S., Fox C. L., et al, PTFE graft treated with silver norfloxacin (AgNF): Drug retention and resistance to bacterial challenge. Journal of Surgical Research, 1987, 42, 298–303.
21. Powell T. W., Burnham S. J., Johnson G. Jr., A passive system using rifampicin to create an infection resistant vascular prosthesis. Surgery, 1983, 94, 765–769.
22. Avramovic J. R., Fletcher J. P., Rifampicin impregnation of a protein-sealed Dacron graft: An infection-resistant vascular graft. Australian and New Zealand Journal of Surgery, 1991, 61, 436–440.
23. Goeau-Brissonniere O., Leport C., Bacourt F., et al, Prevention of vascular graft infection by rifampicin bonding to a Gelatin-sealed Dacron graft. Annals of Vascular Surgery, 1991, 5, 408–412.
24. Chervu A., Moore W. S., Gelabert H. A., et al, Prevention of graft infection by use of prosthesis bonded with a rifampicin/collagen release system. Journal of Vascular Surgery, 1991, 14, 521–525.
25. Ashton T. R., Cunningham J. D., Patan D., Maini R., Antibiotic loading of vascular grafts. Proceedings of the 16th Annual Meeting of the Society for Biomaterials, vol. 13, 1990, p. 235.
26. Farr B., Mandell G. L., Rifampicin. Medical Clinics of North America, 1982, 66, 157–168.
27. Lachapelle K., Graham A. M., Symes J. F., Antibacterial activity, antibiotic retention, and infection resistance of a rifampicin-impregnated gelatin-sealed Dacron graft. Journal of Vascular Surgery, 1994, 19, 675–682.
28. Gahtan V., Esses G. E., Bandyk D. F., et al, Antistaphylococcal activity of rifampicin-bonded gelatin-impregnated Dacron grafts. Journal of Surgical Research, 1995, 58, 105–110.
29. Bergamini T. M., Vascular prostheses infection caused by bacterial biofilms. Seminars in Vascular Surgery, 1990, 3, 101.
30. Sardelic F., Peng Y. A., Fletcher J. P., Establishment of a Staphylococcus epidermidis vascular graft infection model in sheep. Australian and New Zealand Journal of Surgery, 1995, 65, 503–506.
31. Marsan B. U., Curl R., Lakshmikumar P., et al, The thrombosed prosthetic graft is a risk for infection of an adjacent graft. American Journal of Surgery, 1996, 172, 175–177.
32. Martin L. F., Harris J. M., Fehr D. M., et al, Vascular prosthetic infection with Staphylococcus epidermidis: experimental study of pathogenesis and therapy. Journal of Vascular Surgery, 1989, 9, 464–471.
33. Geary K. J., Tomkiewicz Z. M., Harrison H. N., et al, Differential effects of a Gram-negative and a Gram-positive infection on autogenous and prosthetic grafts. Journal of Vascular Surgery, 1990, 11, 339–347.
34. Bergamini T. M., Bandyk D. F., Govostis D., et al, Infection of vascular prostheses caused by bacterial biofilms. Journal of Vascular Surgery, 1988, 7, 21–30.
35. Fletcher J. P., Dryden M., Munro R., et al, Establishment of a vascular graft infection model in the sheep carotid artery. Australian and New Zealand Journal of Surgery, 1990, 60, 801–803.
36. Garrison J. R., Henke P. K., Smith K. R., et al, In vitro and in vivo effects of rifampicin on Staphylococcus epidermidis graft infections. American Society for Artificial Internal Organs Journal, 1997, 43, 8–12.